In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

This smartphone offers a sleek and lightweight design, measuring 162.9 × 76.3 × 7.5 mm and weighing 188 g. It features a glass front with a plastic frame and back, balancing durability and comfort.

Paramount has set Teyana Taylor‘s feature directorial debut, “Get Lite,” for a theatrical release next spring. The film, which will be released wide on April 9, 2027, follows a talented, but sheltered ...

The Acer Swift Lite 14 impresses with its lightweight chassis, 10-hour-plus battery life, and most importantly, its 3K OLED 100 per cent DCI P3 display; Priced at Rs 62,999, the PC utilises the 115U ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...